migraine
Conditions
Interventions
Acupuncture combined with medicine group:horizontal penetration needling and rizatriptan monobenzoate tablets
Western medicine group:rizatriptan monobenzoate tablets
Acupuncture group:horizontal penetration needling
Sponsors
Nanjing Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: 1) Meet the diagnostic criteria of migraine without aura and migraine with aura; 2) Aged 18-50 years, with a history of migraine for more than 12 months; 3) In the acute phase, the pain degree was evaluated by visual analogue scale (VAS) method with 4 points or more; 4) Patients voluntarily received relevant acute analgesia treatment and signed informed consent.
Exclusion criteria
Exclusion criteria: 1) Patients with hypertension and current unstable blood pressure control (stage 2, high-risk patients and above), coronary heart disease (including patients with pacemakers), cerebral infarction and other cardiovascular and cerebrovascular stenosis or obstructive diseases, peripheral vascular stenosis and obstruction; 2) Patients with severe primary diseases such as liver, kidney, digestion and blood system; 3) Mental patients, or patients with infection and bleeding; 4) Pregnant or lactating women; 5) Patients with organic lesions; 6) Patients who cannot understand and cooperate with the visual analogue scale (VAS) method.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 2h Headache remission rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| 2h headache disappearance rate;24h headache remission rate;24h headache disappearance rate; | — |
Countries
china
Contacts
Public ContactRenzhong Kou
Nanjing Hospital of Traditional Chinese Medicine
Outcome results
None listed